These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31925452)

  • 1. The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.
    Ruz-Maldonado I; Liu B; Atanes P; Pingitore A; Huang GC; Choudhary P; Persaud SJ
    Cell Mol Life Sci; 2020 Nov; 77(22):4709-4723. PubMed ID: 31925452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Stimulatory Effects of the CB
    Ruz-Maldonado I; Atanes P; Huang GC; Liu B; Persaud SJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.
    Ruz-Maldonado I; Pingitore A; Liu B; Atanes P; Huang GC; Baker D; Alonso FJ; Bermúdez-Silva FJ; Persaud SJ
    Diabetes Obes Metab; 2018 Apr; 20(4):930-942. PubMed ID: 29205751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
    Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR55 ligands promote receptor coupling to multiple signalling pathways.
    Henstridge CM; Balenga NA; Schröder R; Kargl JK; Platzer W; Martini L; Arthur S; Penman J; Whistler JL; Kostenis E; Waldhoer M; Irving AJ
    Br J Pharmacol; 2010 Jun; 160(3):604-14. PubMed ID: 20136841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
    Romero-Zerbo SY; Rafacho A; Díaz-Arteaga A; Suárez J; Quesada I; Imbernon M; Ross RA; Dieguez C; Rodríguez de Fonseca F; Nogueiras R; Nadal A; Bermúdez-Silva FJ
    J Endocrinol; 2011 Nov; 211(2):177-85. PubMed ID: 21885477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM; Paria BC; Dey SK
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global deletion of G protein-coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β-cell turnover.
    Liu B; Ruz-Maldonado I; Persaud SJ
    Diabetes Obes Metab; 2024 Oct; 26(10):4591-4601. PubMed ID: 39113250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
    Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ
    Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of cannabinoid receptors in mouse islets.
    Li C; Bowe JE; Jones PM; Persaud SJ
    Islets; 2010; 2(5):293-302. PubMed ID: 21099327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.
    Bermudez-Silva FJ; Romero-Zerbo SY; Haissaguerre M; Ruz-Maldonado I; Lhamyani S; El Bekay R; Tabarin A; Marsicano G; Cota D
    Dis Model Mech; 2016 Jan; 9(1):51-61. PubMed ID: 26563389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
    Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
    J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cannabinoid receptors: cellular distribution and biological function.
    Flores LE; Alzugaray ME; Cubilla MA; Raschia MA; Del Zotto HH; Román CL; Suburo AM; Gagliardino JJ
    Pancreas; 2013 Oct; 42(7):1085-92. PubMed ID: 24005231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.
    Kim W; Doyle ME; Liu Z; Lao Q; Shin YK; Carlson OD; Kim HS; Thomas S; Napora JK; Lee EK; Moaddel R; Wang Y; Maudsley S; Martin B; Kulkarni RN; Egan JM
    Diabetes; 2011 Apr; 60(4):1198-209. PubMed ID: 21346174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic β-cells.
    Vong CT; Tseng HHL; Kwan YW; Lee SM; Hoi MPM
    Eur J Pharmacol; 2019 Jul; 854():372-379. PubMed ID: 31054273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function.
    McCloskey AG; Miskelly MG; Moore CBT; Nesbit MA; Christie KA; Owolabi AI; Flatt PR; McKillop AM
    Peptides; 2020 Mar; 125():170251. PubMed ID: 31923454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.